Literature DB >> 1351467

The interactions of ethanol with single and repeated doses of suriclone and diazepam on physiological and psychomotor functions in normal subjects.

D Allen1, M Lader.   

Abstract

The effects of diazepam (5 mg t.i.d.), suriclone (0.2 and 0.4 mg t.i.d.) and placebo (t.i.d.) were assessed in 12 normal, healthy volunteer subjects after a single dose and after treatment for a period of 8 days. A battery of physiological, psychomotor and subjective tests was administered on days 1 and 8 both before and after drug and after a measured dose of ethanol. The effects of diazepam on the EEG were characteristic of benzodiazepines-a decrease in the slow frequency wave-bands, an increase in fast frequency wave-band and diminished evoked response amplitude. Suriclone had similar effects on fast frequency activity and evoked response amplitude but, in contrast to diazepam, also increased the slow frequency wave-bands after 7 days treatment. Some improvements in performance were seen with suriclone on critical flicker fusion, tapping speed, spiral maze and digit cancellation. In contrast, suriclone impaired performance to a greater extent than diazepam on digit symbol substitution and symbol copying. Body sway was also enhanced by suriclone to a greater extent than diazepam. Subjective ratings for mood and adverse-effects showed few differences between suriclone or diazepam. However, suriclone caused greater gastro-intestinal disturbances than diazepam, especially after ethanol, and subjects rated themselves as more antagonistic and more irritable on suriclone. Ratings for calmness suggested that in contrast to diazepam, suriclone had no anxiolytic effect. Several of the parameters tested showed a build up of effect with diazepam over the treatment period which was not seen with suriclone. It is suggested that this difference may be due to differences in elimination rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351467     DOI: 10.1007/bf00314858

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.

Authors:  D Allen; H V Curran; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  A comparative study of the interactions of alcohol with amitriptyline, fluoxetine and placebo in normal subjects.

Authors:  D Allen; M Lader; H V Curran
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1988       Impact factor: 5.067

3.  Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder.

Authors:  M Ansseau; J P Olié; R von Frenckell; G Jourdain; B Stehle; P Guillet
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Differences between cyclopyrrolones (suriclone and zopiclone) and benzodiazepine binding to rat hippocampus photolabelled membranes.

Authors:  J C Blanchard; J L Zundel; L Julou
Journal:  Biochem Pharmacol       Date:  1983-12-01       Impact factor: 5.858

5.  Suriclone: a new cyclopyrrolone derivative recognizing receptors labeled by benzodiazepines in rat hippocampus and cerebellum.

Authors:  J C Blanchard; L Julou
Journal:  J Neurochem       Date:  1983-03       Impact factor: 5.372

6.  Suriclone: a new anxiolytic drug.

Authors:  Y D Lapierre; K L Oyewumi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1983       Impact factor: 5.067

7.  Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG.

Authors:  A Bond; M Lader; R Shrotriya
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Comparative neurologic effects of diazepam and suriclone, a cyclopyrrolone anxiolytic.

Authors:  C A Shaw; E M Sellers; J T Sullivan; H L Kaplan
Journal:  J Clin Psychopharmacol       Date:  1988-06       Impact factor: 3.153

9.  Suriclone and diazepam in the treatment of neurotic anxiety. A double-blind cross-over trial.

Authors:  J Gerlach; J K Christensen; T L Christensen; J Elley; J P Jensen; S B Larsen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 10.  Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic.

Authors:  K L Goa; R C Heel
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

  10 in total
  4 in total

1.  Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects.

Authors:  H V Semlitsch; P Anderer; B Saletu
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  The effects of single doses of CL284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers.

Authors:  D Allen; H V Curran; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.

Authors:  B Saletu; J Grünberger; L Linzmayer; H V Semlitsch; P Anderer; K Chwatal
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

4.  Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects.

Authors:  M J Mattila; J Vanakoski; M E Mattila-Evenden; S L Karonen
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.